Autolus Therapeutics (AUTL)

• Market cap: $365M
• 1 day: -1.44%
• 5 days: 3.01%
• 1 month: -16.97%
• 3 months: -14.91%
• 6 months: -12.74%
• Year to date: -47.91%
• 1 year: -55.81%
• 5 years: -85.74%
• 10 years: -94.52%
• Sector: Healthcare
• Industry: Biotechnology

About: Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Employees: 647